Mining Giants Weigh $39 Billion Megadeal 
 

Mining giant BHP has offered to buy longtime rival Anglo American in a deal that could reshape the global industry.


 
Southwest to Exit Four Airports as Boeing's Problems Ripple Through Industry 
 

Its adjusted quarterly loss was worse than expected despite record operating revenue fueled by strong travel demand.


 
Dow Earnings Say the Global Economy Is Good, but Not Great 
 

Chemicals giant Dow reported strong first-quarter earnings, but an outlook of a slowing global economy spooked investors.


 
Hertz to sell 10,000 more EVs than planned and swings to a large loss 
 

Hertz's stock resumed its selloff on Thursday, after the rental car company reported a much wider-than-expected first-quarter loss, and significantly expanded its plan to sell off its electric vehicles.


 
Comcast Earnings Top Estimates on a Rise in Peacock Subscribers 
 

Comcast says Peacock revenue in the first quarter increased 54% to $1.1 billion, while paid subscribers jumped 55% to 34 million.


 
Caterpillar Stock Falls After Earnings. Here's Why. 
 

Caterpillar reports adjusted first-quarter earnings of $5.60 a share. Wall Street expected profit of $5.14.


 
GE Vernova Stock Falls After Earnings Beat. That Makes Sense. 
 

GE Vernova stock is down after the company reported better-than-expected first-quarter results. The reaction to Thursday's earnings came on Tuesday.


 
Altria's earnings top estimates and tobacco company reaffirms full-year guidance 
 

Altria Group Inc. matched profit estimates for the first quarter, while revenue net of excise taxes squeezed a small beat and the company backed its full-year guidance, reiterating its stance that there will be limited impact from enforcement efforts in the illicit e-vapor market in 2024.


 
Harley-Davidson posts stronger-than-expected profit, but shares cool 
 

Motorcycle icon says total sales fell.


 
Merck's first-quarter results beat expectations amid healthy vaccine-sales growth 
 

Merck on Thursday reported first-quarter results that beat analysts' expectations amid strong sales of vaccines and cancer drug Keytruda.


(END) Dow Jones Newswires

04-25-24 0915ET